Kamada (KMDA) Stock Price, Quote, News & History | Benzinga

Kamada (KMDA) Stock Price, Quote, News & History

KMDANASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$8.32

-0.05-0.60%

At close: Jan 30, 4:00 PM EST

$8.32

N/A

After Hours: 4:02 PM EST

Overview

News Earnings Options Guidance Dividends Analyst Ratings Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$8.44

Close

$8.32

Volume / Avg.

57.34K / 81.39K

Day Range

$8.20 - $8.53

52 Wk Range

5.54 - 9.15

Market Cap

$479.91M

P/E Ratio

23.91

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

0.23%

Days to Cover

1.42

Recent Kamada Ltd News

Partner Content

Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio

Kamada Shuts Down Phase 3 Study For Genetic Condition, Reiterates Outlook

Kamada ends its Phase 3 inhaled AAT trial after a futility analysis but maintains 2025 guidance and forecasts double-digit growth in 2026.

Vandana Singh

Partner Content

Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

28.32M

Investing Cash Flow (TTM)

-9.99M

Financing Cash Flow (TTM)

-17.87M

Free Cash Flow (TTM)

18.33M

Capital Expenditure (TTM)

-9.99M

Net Change in Cash (TTM)

461.00K

Analyst Trends and Forecast

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$423.78M

PE Ratio (TTM)

23.91

PE Ratio (FWD)

18.76

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.80

PB Ratio (TTM)

1.82

Earnings Yield % (TTM)

4.18%

Earnings Yield % (FWD)

5.33%

EV / EBITDA (TTM)

11.37

Price / EBITDA (TTM)

13.15

Price / Free Cash Flow (TTM)

26.70

Book Value / Share

$4.60

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.19M

Total Cash

$72.00M

Debt to Equity

0.04

Issuance of Debt (TTM)

-$1.19M

Repayment of Debt (TTM)

-$1.19M

Key Statistics

Open

$8.44

Close

$8.32

Volume / Avg.

57.34K / 81.39K

Day Range

$8.20 - $8.53

52 Wk Range

5.54 - 9.15

Market Cap

$479.91M

P/E Ratio

23.91

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

0.23%

Days to Cover

1.42

About

Sector

Health Care

Industry

Biotechnology

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists...

Show More

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Kamada (KMDA) stock?

A

You can purchase shares of Kamada (NASDAQ:KMDA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kamada (KMDA) competitors?

A

Other companies in Kamada’s space includes: 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Monopar Therapeutics Inc (NASDAQ:MNPR), ADC Therapeutics SA (NYSE:ADCT), Prothena Corp PLC (NASDAQ:PRTA) and DiaMedica Therapeutics Inc (NASDAQ:DMAC).

Q

What is the forecast, or price target, for Kamada (KMDA) stock?

A

Kamada has a consensus price target of $14.25.

Q

What is the current price for Kamada (KMDA)?

A

The stock price for Kamada (NASDAQ: KMDA) is $8.32 last updated January 30, 2026 at 4:02 PM EST.

Q

Does Kamada (KMDA) pay a dividend?

A

There are no upcoming dividends for Kamada.

Q

When is Kamada (NASDAQ:KMDA) reporting earnings?

A

Kamada does not have any upcoming earnings scheduled.

Q

Is Kamada (KMDA) going to split?

A

There is no upcoming split for Kamada.

Q

What sector and industry does Kamada (KMDA) operate in?

A

Kamada is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

4D Molecular Therapeutics Inc

Monopar Therapeutics Inc

ADC Therapeutics SA

Prothena Corp PLC

DiaMedica Therapeutics Inc

Kyverna Therapeutics Inc

PureTech Health PLC

Bicycle Therapeutics PLC